title: Sorafenib: osteonecrosis of the jaw.
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D007568:Jaw / Q000187:drug effects / Q000473:pathology; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D010020:Osteonecrosis / Q000139:chemically induced* / Q000473:pathology; D010671:Phenylurea Compounds / Q000009:adverse effects* / Q000494:pharmacology; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000494:pharmacology; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D009536:Niacinamide; D000077157:Sorafenib